NAT10 and cancer: Notably, the mRNA expression of NAT10 in Remodelin-treated cancer cells were significantly downregulated in MCF7 and MDA-MB-468; however, no significant difference was recorded in T47D when comparing Remodelin-treated vs. control (Figure 5C).